XORTX Therapeutics Inc (XRTX)
2.99
+0.40
(+15.44%)
USD |
NASDAQ |
Apr 26, 12:08
XORTX Therapeutics Price to Book Value: 0.9820 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 0.8506 |
April 24, 2024 | 0.953 |
April 23, 2024 | 0.9655 |
April 22, 2024 | 0.9852 |
April 19, 2024 | 0.9843 |
April 18, 2024 | 1.002 |
April 17, 2024 | 1.041 |
April 16, 2024 | 1.018 |
April 15, 2024 | 1.058 |
April 12, 2024 | 1.103 |
April 11, 2024 | 1.168 |
April 10, 2024 | 1.154 |
April 09, 2024 | 1.251 |
April 08, 2024 | 1.282 |
April 05, 2024 | 1.215 |
April 04, 2024 | 1.159 |
April 03, 2024 | 1.067 |
April 02, 2024 | 1.108 |
April 01, 2024 | 1.195 |
March 28, 2024 | 1.215 |
March 27, 2024 | 1.182 |
March 26, 2024 | 1.248 |
March 25, 2024 | 1.256 |
March 22, 2024 | 1.461 |
March 21, 2024 | 1.588 |
Date | Value |
---|---|
March 20, 2024 | 1.442 |
March 19, 2024 | 1.626 |
March 18, 2024 | 1.593 |
March 15, 2024 | 1.698 |
March 14, 2024 | 1.777 |
March 13, 2024 | 1.629 |
March 12, 2024 | 1.586 |
March 11, 2024 | 1.461 |
March 08, 2024 | 1.566 |
March 07, 2024 | 1.514 |
March 06, 2024 | 2.052 |
March 05, 2024 | 1.576 |
March 04, 2024 | 1.130 |
March 01, 2024 | 1.075 |
February 29, 2024 | 0.9984 |
February 28, 2024 | 1.095 |
February 27, 2024 | 0.8995 |
February 26, 2024 | 0.9163 |
February 23, 2024 | 0.7915 |
February 22, 2024 | 0.8801 |
February 21, 2024 | 0.798 |
February 20, 2024 | 0.8867 |
February 16, 2024 | 0.7323 |
February 15, 2024 | 0.7455 |
February 14, 2024 | 0.7225 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6601
Minimum
Dec 28 2023
579.03
Maximum
Jul 30 2019
13.96
Average
1.876
Median
Jan 04 2023
Price to Book Value Benchmarks
ImmunoPrecise Antibodies Ltd | 0.9022 |
Acasti Pharma Inc | 0.4244 |
Aurinia Pharmaceuticals Inc | 1.884 |
Edesa Biotech Inc | 2.425 |
Lexaria Bioscience Corp | 4.505 |
Price to Book Value Related Metrics
Price | 2.99 |
Earnings Yield | -121.0% |
Market Cap | 5.976M |